The second part of this overview on early severe ARDS delineates the pros and cons of the following: a) controlled mechanical ventilation (CMV: lowered oxygen consumption and perfect patient-to-ventilator synchrony), to be used during acute cardio-ventilatory distress in order to "buy time" and correct circulatory insufficiency and metabolic defects (acidosis, etc.); b) spontaneous ventilation (SV: improved venous return, lowered intrathoracic pressure, absence of muscle atrophy). Given a stabilized early severe ARDS, as soon as the overall clinical situation improves, spontaneous ventilation will be used with the following stringent conditionalities: upfront circulatory optimization, upright positioning, lowered VO 2 , lowered acidotic and hypercapnic drives, sedation without ventilatory depression and without lowered muscular tone, as well as high PEEP (titrated on transpulmonary pressure, or as a second best: "trial"-PEEP) with spontaneous ventilation + pressure support (or newer modes of ventilation). As these propositions require evidence-based demonstration, the reader is reminded that the accepted practice remains, in 2016, controlled mechanical ventilation, muscle relaxation and prone position.
a. Muscle relaxation
In severe ARDS (P/F < 120), muscle relaxation [2] lowered the mortality (45 to 31%; difference of −32%; P = 0.04), multiple organ failure (MOF), and barotrauma and led to more ventilator-free days and identical CCU-acquired paresis. Muscle relaxation was hypothesized to minimize excessive transpulmonary pressure, patient-to-ventilator asynchrony [2] , ventilator-induced lung injury (VILI), atelectrauma, overdistension, the release of mediators [3] , and lowered inflammation [4] . This trial [2] demonstrates only that perfect ventilator−patient synchrony (pneumothorax: placebo: 11.7%; muscle relaxant : 4%; P = 0.01) and lowered oxygen consumption (VO 2 ) lower mortality in the setting of early ARDS. [Nothing more: this excellent paper [2] does not demonstrate that muscle relaxants are the only way to achieve ventilator-to-patient synchrony nor lowered VO 2 ]. Most commentators overlook setting up PS as soon as possible after 24 h [5] or 48 h of muscle relaxation [2, 6] . This design [2] is in line with the optimized circulation/cardiological strategy: "As soon as some improvement was observed, pressure support ventilation was started " [7] . Indeed, a muscle relaxant lowered the VO 2 during the early phase of ARDS (controlled mechanical ventilation: CMV vs. CMV+muscle relaxation: VO 2 reduced by −8%; CMV+muscle relaxation vs. continuous positive airway pressure: CPAP: −18% [8] ).
In brain-dead patients, 18−69 h of diaphragmatic inactivity combined with CMV resulted in marked atrophy in the diaphragm myofibers [9] . The functional consequence was demonstrated in patients undergoing CMV for at least 5 days; a time-related decrease in diaphragmatic function was observed as early as day 0−1 and dropped to 32% of the baseline value after 6 days of CMV [10] . Does a 48 h time course of controlled mechanical ventilation, with or without paralysis, generate ventilator-induced diaphragmatic dysfunction?
[Although most would agree that acute cardio-ventilatory distress (11) requires lowered VO 2 and WOB, including transient muscle relaxation, switching to spontaneous ventilation is too often not adhered to, as emphasized earlier [6, 7, 12] . In our daily practice, we observe that overlooking this early transition from muscle relaxation to PS prolongs muscle relaxation, sedation (i.e. de facto general anesthesia), CMV and leads to CCU-acquired diseases (e.g., ventilatorinduced diaphragmatic dysfunction, sepsis, delirium, and MOF). Thus, after 48 h or more of muscle relaxation the patient cannot be weaned from the muscle relaxant, sedation and/or ventilatory support: a vicious cycle has been created (iatrogenic disease), generating late ARDS and late MOF. Fibrosis superimposes itself on atelectasis, inflammation and increased lung water. The reduction in work of breathing (WOB) has not been analytically addressed upfront. Sedation is inappropriate (Table I part II) , thereby evoking respiratory depression and/or emergence delirium. Borrowing general anaesthesia from the operating room in the CCU, revamped as "analgo-sedation", is inappropriate: the patient needs only indifference both to the CCU environment and to pain (ataraxia and analgognosia i.e. "cooperative sedation") [13, 14] . In a setting different from severe ARDS, minimal sedation appears suitable [15] . Our argument is not against the transient [16] use of muscle relaxation in the setting of acute cardio-ventilatory distress in order to buy time and correct analytically (Table 1 part II) this "shock state" but against any prolonged use of analgo-sedation combined with muscle relaxation leading to a descent into MOF and CCU-acquired diseases. Indeed, [use of [muscle relaxation] remains a last resort [17] , i.e. after a thorough analysis of the VO 2 , respiratory rate (RR), tidal volume (Vt), acidosis (H+), CO 2 , and O 2 . [6, 9, 10, 12] .
If muscle relaxation is selected in order to handle the acute cardio-ventilatory distress, the shorter it is, the better

b. spontaneous ventilation
Because pressure support (PS) allows the selection of fixed driving pressure but not transpulmonary pressure and Vt, all of the parameters interact with one another. We will first cover transpulmonary pressure, then the respiratory rate (RR).
Pressure suPPort
During the weaning of chronic obstructive pulmonary disease (COPD) patients, suppressed sternocleidomastoid (SCM) electrical activity suggests suppressed diaphragmatic fatigue. In COPD patients, a PS = 10 cm H 2 O suppressed SCM activity in 5/8 patients while a PS = 20 cm H 2 O eliminated diaphragmatic fatigue in the remaining patients ( Fig. 3 in [18] ). The optimal PS was associated with a Vt = 5−9 mL kg −1 and an RR = 20−35 breaths per min [18] . Increasing the PS from 0 to 20 cm H 2 O decreased the VO 2 (288 ± 49 to 213 ± 54 mL min −1 ; −26%) [18] . As the electrical activity of the SCM muscle is greater when diaphragmatic fatigue is present [18] , the adequacy of the PS driving pressure may be approached through palpation of the SCM muscle. The PS should be diminished step by step from a high value (e.g. 15−20 cm H 2 O) until phasic SCM activity re-appears. Then PS is increased immediately above this level to avoid diaphragmatic fatigue, overdistension and apnea. The PS would allow minimal diaphragmatic activity without fatigue, at least in COPD patients [18] . During weaning, PS reduced the weaning duration and CCU stay [19] .
PS vs. APRV:
Firstly, APRV appeared superior to volumecontrolled ventilation (inverse inspiratory to expiratory ratio) in mild ARDS [20] . Under APRV, several indices improved over a 16 h period (Ppeak, decreased shunt, and improved ventilation/perfusion ratio: VA/Q). In this respect, after 24 h, SV accounted for 34 ± 14% of the total ventilation [20] .
Secondly, APRV+SV led to a lower Ppeak, lower RR and higher PaO 2 /FiO 2 (P/F) compared with pressure-controlled ventilation [21] . Importantly, by day 1, patients with a similar P/F (~250) at inclusion worsened back to moderate ARDS (P/F < 200) in the pressure-controlled group. In contrast, the P/F improved to above P/F >300 in the SV+APRV group [21] , and was associated with a reduced CCU stay (APRV+SV: 23 days; pressure controlled ventilation: PCV: 30 days) [21] . Moreover, a higher cardiac index and lower requirements for vasopressor, inotrope and sedative drugs were observed in the APRV+SV group [21] . Hence, SV preserves the VA/Q better than CMV because a higher P/F was observed when the SV accounted for ~10% of the total ventilation [21] . Table 1 . An alternative strategy in early severe diffuse ARDS [27, 28, 30, 71] ?
[I Working hypothesis [27, 30] : a) to minimize the alveolar "penumbra area" (i.e. increase the size of the baby lung [102] ) next to the true atelectatic areas without RV afterloading as opposed to re-expanding all atelectatic areas at once ( 1) Ascertain severe ARDS: P/F < 100 after 30 min (Vt ~7 mL kg −1 , PEEP = 10 cm H 2 O, FiO 2 = 1) [60] 2) Optimize circulation (cardiological strategy): a) rule out patent foramen ovale, especially if no oxygenation response to PEEP elevation (Dessap 2010 in part I) b) avoid a "low PvO 2 effect" [7] and RV dysfunction 3) Use an upright position [81] and lower intra-abdominal pressure (gastric, bladder and colonic drainage: early facilitation of bowel movements) 4) Normalize the temperature (≈36°C) to lower the VO 2 [16, 45, 70] and VCO 2 , leading to a low Vt (≤ 5 mL kg −1 ; consider veno-venous CO 2 removal 5) Normalize acidosis (optimized cardiac output: CO 2 gap < 5−6 mm Hg; SscvO 2 > 70−75%; early EER therapy to lower lactates ≤ 2; infection control; rare administration of buffer) in order to lower the RR. This is the pathophysiological cornerstone of this alternative strategy because ARDS occurs rarely as single-organ failure but most often within the context of septic shock and early MOF 6) CO 2 : avoid major hypercapnia [55] in order to lower the risk of RV failure and increased RR 7) O 2 : a high FiO 2 will lower RR in SV [40] 8) SV should be set stringently only following control of ventilatory demands and metabolic demands
Measure the PEEPi prior to switching to SV and consider bronchodilators High PEEP to suppress cyclical end-expiratory collapse, atelectrauma and WOB early on.
Select a low PS to avoid large transpulmonary pressure and volotrauma [35] Set low inspiratory trigger, high pressure rise time [57] , low expiratory trigger [59] , automatic tube compensation = 100% [56] 9) Sedation: an absence of respiratory depression [94] should be considered as the pharmacological cornerstone of all of the cardio-ventilatory physiology discussed throughout ms. If necessary, alpha-2 agonists should be combined with neuroleptics, to −3 < RASS < −2 [13] a) all the optimization of the cardio-ventilatory physiology, delineated in these two chapters, is useless if the respiratory generator is not free of any depressing influence [94] b) conversely, alpha-2 agonists, without optimized cardio-ventilatory physiology, are useless.
10) revert to proning, muscle relaxants and CMV would this alternative strategy fail
III. Limitations:
This alternative strategy does not apply to the patient with:
1) acute cardiopulmonary distress ("shock" state): an ultra-short course of controlled mechanical ventilation combined to muscle relaxation (e.g., 1−6 h) allows one address pre-arrest emergency, re-oxygenate the patient, optimize circulatory function, lower oxygen consumption, insert the lines, perform echocardiography, CT scan, fiberoptic bronchoscopy, and initiate extra-renal replacement at once, as neatly summarized [11] 2) severe metabolic/lactic acidosis [28] : a strong H + stimulus requires muscle relaxation to lower RR and CO 2 production. Accordingly, a pH > 7.23−7.29 is needed to switch to SIMV [83] . Early extra-renal replacement therapy should be considered aggressively. SV should pick up as soon as H + is controlled (e.g., pH ≥ 7.30?)
3) severe denutrition or acquired myoneuropathy following prolonged CCU stay or use of sedative agents: ventilatory muscle failure and delirium should be addressed upfront, before heading to SV
IV. Position:
To lower Pplat, changes in intra-thoracic pressure from the upright to the supine position [104] should be kept in mind. Abdominal pressure [105] is lowered (gastric, bladder and colonic drainage, early facilitation of bowel movements). Thus, to us, "upright" position (reverse Trendelenburg, 60° head-up position, 45° legs down) appears for bipeds the most appropriate position to allow for adequate gas exchange [79−81] , especially when high chest wall elastance (obesity, increased IAP, etc.) requires high PEEP to achieve the appropriate transpulmonary pressure. There is no short cut to improve the VA/Q ratio: the reader should be aware that an upright position needs tedious repositioning. The upright position will restore a functional "zone 3" (Fig. 11 in [96] ). Given a high PEEP, an active diaphragm will unfold the collapsed alveoli while the gravity will fill up the capillaries with blood, optimizing the VA/Q ratio V. Lowering VO 2 ( Fig. 1 in [16] ; Fig. 1 in [82] ):
As stated in the introduction, the intensivist should deal, analytically and therapeutically, in a differentiated manner high ventilatory ventilatory demands (large Vt, high RR : "soif d'air") as opposed to high metabolic demands (fever, agitation, sympathetic activation, etc.). These 2 types of demands are inter-related. An anti-infectious strategy should be considered upfront. Next, the respiratory muscles capture some 21% of the cardiac output in spontaneously breathing dogs experiencing cardiac tamponade [106, 107] . Thus, RR should remain low [39] . By extension WOB is the limiting factor. To lower RR and VO 2 , minimizing the hypercapnic [55] and acidotic drives, and normothermia (36°C), are mandatory, especially in the presence of septic shock (hypoxic drive: see below). As lowering the temperature by ≈2.4°C lowers VO 2 by 18% [70] , normothermia increases the cardioventilatory reserve [45] and allows one to lower Vt and RR (≈36°C via extrarenal replacement therapy or a cooling device and/or pharmacology: paracetamol/ /alpha-2 agonists [82, 108, 109] ). Muscle relaxants are of great value [8] , transiently, only during acute cardio-ventilatory distress [16] Upfront circulatory improvement will: a) rule out a patent foramen ovale: when a low PvO 2 effect has been ruled out, an absence of oxygenation response to PEEP elevation requires looking for PFO then perform a CT scan (responders vs. non-responders: Table 6 , part I, § trial-PEEP) b) correct a much-overlooked "low PvO 2 effect" [7, 110] : the cardiac output should return to adequacy (SsvcO 2 > 70−75% or a difference in arterialcentral venous O 2 saturation < 30%, CO 2 gap < 5−6 mm Hg, adequate trend in lactate heading < 2 mmol L −1 ) c) avoid RV dysfunction (septal bulging) caused by high PEEP [111] or hypercapnia [55] Given the difficulty in assessing micro-circulation, circulatory optimization implies adequate urine output, in the absence of extra renal replacement therapy. Repeated echocardiographies look for septal leftward bulging or reduced LV preload in the setting of high PEEP
VII. Analysis of the blood gases:
Each This strategy bases itself on repeated RV echocardiographic assessments (no leftward septal bulging), physiological measurements (P−V curve [112] or esophageal balloon: end-expiratory [48] transpulmonary pressure) or, if the balloon is unavailable, (SaO 2 > 88−92% in the setting of CMV [41, 42] as opposed to SaO 2 > 95−100% in the setting of SV [40] ). This high stretch strategy regarding recruitment (balloon or P-V curve or trial-PEEP) wil suppress cyclical alveolar collapse and optimize ventilation (high numerator in VA/Q ratio). Once high PEEP resets lung volume to higher FRC, changing CMV to SV allows one to lower Pplat, reduce circulatory [113] and muscular [9, 10] effects of positive pressure ventilation. Moreover, a lowered Pplat evoked by an upright position and PS will allow one to implement higher PEEP levels (15−24 cm H 2 O), generating a swifter resolution to alveolar collapse. A 12 h trial of high PEEP segregate responders vs. non-responders (Table 6, [115] ) PEEP is used, the lung is constantly above the closing volume, thus set on the highest slope of the P−V curve [114] . High PEEP, when adequate [76] , allows the lung to operate on the part of the P−V curve (incremental limb [116] ; decremental [49] ) with the highest slope [114] ( Fig. 2 in [114] : "best compliance" [117] in "safe window": Figure 1 in [115] ). Given this high slope, a small increment in pressure generated by low PS generates in turn a large change in volume. The higher the PEEP needed to keep the lung above closing volume, the smaller the tidal volume needs to be [51, 115] (Fig. 2 in [114] ). Indeed, a sigh (i.e., twice the Vt) leads rarely to Pplat = 40 cm H 2 O when a high "optimal" PEEP is used [53] . Presumably keeping the diseased lung above FRC minimizes pressure injury [50] , despite repetitive sighs and high PEEP [53] . This applies to either high frequency ventilation (HFV), or protective ventilation (Vt ≤ 5 mL kg −1 ), or a very low level of PS b) the diaphragm generates negative intrapleural pressure which adds on mechanical support (for limitations: see PS and transpulmonary pressure; Figs 1 and 2 in [33] ). c) to overcome the WOB generated by the valves and tubing in healthy volunteers, PS = 3−5 cm H 2 O is needed [118] . The implication is that the baby lung has a normal compliance. Nevertheless, the accessory muscles should be at rest all the time: automatic tube compensation [56] will perform nearly all WOB: no sternal notch retraction, no use of accessory muscles, etc. Therefore, PS had to be set to a surprisingly low level (3−10 cm H 2 O, low inspiratory trigger, low expiratory trigger [59] , high pressure rise time, automatic tube compensation 100%) in patients presenting with early severe ARDS undergoing moderate permissive hypercapnia (PaCO 2 £ 60 mm Hg) [55] under high PEEP (15−24 cm H 2 O) [30, 71] . These observations agree with earlier findings [18, 35, 36] . Negative intrapleural pressure (generated by an active diaphragm) and a high slope above closing volume lead to a low PS and small Vt sufficient to maintain acceptable PaCO 2 . PEEP set in order to achieve the highest slope of the deflation limb of the P−V curve combines with minimal transpulmonary pressure. Trial-PEEP based on oxygenation [54] a) PS level: The PS level is progressively lowered from 10 cm to lower values (≈5 cm H 2 O), as long as the patient presents no discomfort, no sternal notch retraction, no use of the sternocleido-mastoid muscle. To our surprise, high PEEP combined to "Smart Care" software (Evita 4 XL/Infinity V500, Drager) allows one to achieve early and easy weaning in the setting of severe acute hypoxemic failure in a morbidly obese patient [30] b) FiO 2 ( This result could be due to an active diaphragmatic contraction, throughout inspiration, the recruitment of previously unventilated alveoli, or to a redistribution of the flow towards previously ventilated lung units. Additionally, PS appears to be superior to CMV but inferior to APRV+SV [22, 23] . Accordingly, when P/F < 300, APRV appears to be superior compared to PS. Unfortunately, the analysis does not further segregate P/F < 100 vs. P/F < 200. Similar favourable results were observed in 8 moderate/ /severe ARDS under APRV [24] . Third, lung aeration appears to be superior upon APRV+SV as opposed to PS in patients with a high proportion of severe ARDS (aerated lung from 29 to 43% as opposed to 39 to 44%, respectively). Given a similar airway pressure, a greater increase in the P/F was observed with APRV compared to PS (APRV: 79 to 398; PS: 96 to 249). A higher MAP was observed under APRV+SV than under PS and was presumably linked to an active compression of blood from the viscerae by the diaphragm [25] . The reader should note that, presumably, very low P/F values [40−66] were handled with spontaneous ventilation [26] .
Despite these physiological data, an epidemiological study ("BIRDS" trial: clinicaltrials.gov/ct2/show/ NCT01862016) is required to assess the CMV vs. APRV+SV comparison and to determine which SV mode should be used. At present, given stringent [27−30] conditions, spontaneous ventilation improves gas exchange upon ARDS [21] .
transPulmonary Pressure and tidal volume: "naïve" Pressure suPPort?
Large transalveolar pressure and tidal pressure excursions (ªPplat) are the determinants of tissue damage [31] . A transpulmonary pressure of PL = 15 cm H 2 O generates a Vt of ~2500 mL (i.e., 2/3 of the total lung capacity) [32] . While marathon runners can withstand a Vt >25 mL kg −1 for 2−3 hours [31] , it does not follow that a "baby lung" may withstand a Vt >5 mL kg −1 for weeks. The transpulmonary a) PS against newer modes of ventilation: Neurally Adjusted Ventilatory Assist (NAVA) is more appealing to further ventilator-to-patient synchrony and maintain breathing variability [119] . Accordingly, APRV with spontaneous ventilation [24] is more efficacious than PS [88] , based on the distribution of blood flow to unventilated areas [23, 120] . Epidemiologic data are lacking to select the best ventilatory mode under spontaneous ventilation (BIRDS: https://clinicaltrials.gov/ct2/show/NCT01862016)
IX. Sedation:
At variance with current practice, treatment of early severe ARDS should not rely only on stringent cardio-ventilatory physiology but also on stringent brain stem neurophysiology [94] . A sedation devoid of circulatory and ventilatory side-effects is the key pharmacological issue: alpha-2 agonists, devoid of respiratory depressant effects [94, 121] are to be administered to −3 < RASS < −2 [13] . If high-dose alpha-2 agonists do not generate enough quietness, neuroleptics are to be added: loxapine, haloperidol [13, 122, 123] ). Alpha-2 agonists generate no emergence delirium and prolonged elimination, and alter the hypothalamic set-point [124] thus causing slight hypothermia (≈ 35,5°C) [108, 109, 125] and lower VO 2 during weaning [82] . Thus, "cooperative" sedation [13, 126] , or little/no sedation [15, 127] in non-combative patients, are to be considered [27, 30, 71] . Then, new ventilator modes (PS, APRV, etc.) will be used within the most appropriate pharmacological setting
Provided that volemia is optimized (little or no ventilator-evoked variations in vena cava, little or no increase in cardiac output or BP following passive leg rising), sympathetic de-activation through the use of alpha-2 agonists warrants interest: a) increased pressor response to noradrenaline in the setting of septic shock [128, 129] or experimental sepsis [130, 131] b) reduced pulmonary hypertension [132] c) increased diastolic compliance [133] d) reduced intraabdominal pressure [134] e) reduced microvascular permeability [135] , of interest as high pulmonary water content is considered [136] . In this respect, the reader should note that alpha-adrenergic blockade decreases pulmonary extravascular leakage in the setting of experimental haemorrhage [137] f) diuresis [138] in the setting of ascites [139−141] , cardiac failure [142] and critical care [143] g) lowered pro-inflammatory IL6 [144] , increased anti-inflammatory IL10 [145] The use of SV in the setting of early severe diffuse ARDS remains seldom used [39, 40] . This lack of enthusiasm may be related to the absence of epidemiological data: a) clearly, the mode of ventilation was selected appropriately, e.g., [21] , with a reduction in CCU stay. Accordingly, the present BIRD trial (clinicaltrials. gov/ct2/show/NCT01862016) uses a combination of APRV+SV b) thus we surmise that conventional sedative agents were selected inappropriately: alpha-2 agonists [13, 122] do not suppress the respiratory drive [94] , but suppress the emergence delirium. Non-conventional sedation with alpha-2 agonists is by itself unlikely to modify outcome [146, 147] : by contrast, the combination of stringent spontaneous ventilation and alpha-2 agonists is mandatory in order to achieve superiority [148] Two final observations are required, namely: a) would this alternative strategy be a failure (tachypnea, high or low Vt, acidosis, absence of improvement of P/F, etc.), reverting early to proning+CMV+muscle relaxation [2, 63] (36) . This may create overdistension [35] , making a high PS potentially detrimental [35] (Figs 1 and 2 in [33] ). The spontaneous engagement of the diaphragm may lead to regional variation in the transpulmonary pressure (greatest in dependent regions) with greater recruitment of the lung volume and possibly further VILI in a "baby lung". The transpulmonary pressure may still be high with the danger of a large Vt while the low airway pressure may look deceptively safe (Figs 1 and 2 in [33] ). In this respect, inflation of the dependent regions at the expense of the non-dependent regions has been observed at identical tidal and lung volumes i.e. pendel-luft [37] (Figs 1 and 2 in [37] ). This pendelluft may inflate the atelectatic regions and improve lung recruitment. Conversely, the pendelluft may worsen local lung injury when associated with the intrinsic positive end-expiratory pressure (PEEP) or a triggering delay [37] (Fig. 1 in [37] ). These data [37] were only partially conclusive because the patient was acidotic (pH = 7.28, BE = −8 mmol L -1 , Vt = 7.8 mL kg −1 , possibly associated with high inspiratory efforts). Nevertheless, they [37] point out that a "naïve" [35] use of SV may worsen lung injury.
To summarize, spontaneous ventilation should not generate a high transpulmonary pressure [35, 36] (Figs 1 and 2 in [33] ; Fig. 1 in [37[ ). Both "early" ( § I B 1) and "late" inspiration are to be checked: under PS, setting the Pplat £ 26−32 cm H 2 O does not automatically protect against VILI unless the Vt [36] or esophageal pressure are monitored.
Pressure suPPort and resPiratory rate
Late vs. early ARDS: In transitioning to SV, swiftness is mandatory. The use of PS was successful in early ARDS as opposed to its failure in late ARDS [38] . Indeed, patients successfully transitioned to PS presented a shorter duration of CMV (success ~10 d of CMV; failure ~20 d, presumably due to fibrosis during late ARDS; inclusion: 48 patients with > 7 days of intubation, P/F = 210 ± 69, PaO 2 > 80 mm Hg, PEEP >15 cm H 2 O, and any FiO 2 ) [39] . Immediately following the transition to PS, the P/F was unchanged, the PaCO 2 and mean airway pressure (~15 cm H 2 O to ~13) were decreased, and the pH, minute ventilation and RR were increased. PS failure occurred at a later interval (≈20 ± 8 h) and was correlated with a longer duration of intubation, increased RR, higher PaCO 2 , lower P/F, higher Vd, Vd/Vt, Ppeak and pulmonary pressure and similar or lower Vt (similar PEEP ~9 cm H 2 O irrespective of success or failure). Thus, success comprised: 79% of the 48 patients, PS ~14 cm H 2 O over 48 h; and a minimal increase in RR: 15 ± 4 to 22 ± 6, while failure comprised: PS≈22 cm H 2 O; major increase in RR: 19 ± 4 to 36 ± 13 cycles per min (cpm); increased PaCO 2 ; decreased PaO 2 ; and circulatory instability) [39] . The "naïve" [35] use of SV may be detrimental when the patient is unable to select an appropriate RR by himself. (Table 4 , part I and Table 2 , part II): An illquoted paper beautifully demonstrated that ARDS patients under PS ventilation experienced a decrease in RR from 34 to 25 cpm when the PaO 2 was increased from 55 to 158 mm Hg [40] (Table 4B , part I). [AETherefore, a SaO 2 level close to 95−100% should be the goal during the weaning period of severe ARDS under SV in order to lower the RR and WOB, thus allowing early transition to SV. This practice (SaO 2 = 95−100% under spontaneous ventilation-PS) [40] contrasts with weaning COPD patients who tolerate a SaO 2 ≈85−90% and the extension of this COPD practice to stabilized early severe ARDS under CMV (target: SaO 2 = 88−92% to avoid O 2 toxicity [41, 42] . The use of SV in early severe ARDS implies stringent conditions (e.g., high SaO 2 to lower the RR)¨].
Hypoxic drive
Acidosis: Experimentally, injection of sodium salicylate into the cisterna magna generate threefold increases in Vt, RR and minute ventilation. Some animals died. By contrast, following barbiturates and muscle relaxants no changes and no death occurred [43] . Indeed, the clinician is well aware of hyperventilation and increased RR in the setting of head injury, diabetic ketoacidosis, high altitude edema, severe haemorrhage and drug intoxication, as well as in ARDS [44] .
If SV is considered, lowered VO 2 [45] and minimized RR [40] are mandatory. Briefly, all the factors influencing Vt and RR are to be minimized (temperature, H + , CO 2 , central noradrenergic-peripheral sympathetic activity, agitation) to handle the oxygenation defect itself.
Setting up CMV vs. SV: a) In the setting of CMV, the Vt/driving pressure should be set first, prior to increasing the PEEP to an acceptable Pplat [46] . When the CMV is considered with a fixed Vt ≤ 5−6 mL kg −1 , setting the PEEP is based on either lung mechanics (Pplat [46] , or end-inspiratory transpulmonary pressure [47] ), or oxygenation combined with lung mechanics (end-expiratory transpulmonary pressure [48] ), or the decremental [49] [To consider a few of the issues at stake:
I. Setting PEEP:
Irrespective of any "open lung" approach, leftward septal bulging is to be avoided: the right ventricle is a low-pressure generator.
Is volu-or barotrauma (Table 5 , part I) linked to a high PEEP and/or to the amplitude of the absolute Pplat? to the transpulmonary end-inspiratory pressure?
Is volu-or barotrauma linked to the total duration of the mechanical ventilation? The literature (7, 62) does not provide clear-cut answers (Table 5 , part I). Amato states: lung "damages are more closely related to the amplitude of cyclic stretch than to the maximal level of stretch" [50] . 2) given an identical area under the Pplat = f(time) curve, is a high PEEP (e.g., 20−24 cm H 2 O), or a high Pplat, for a short period of time (6−12 h up to 72 h) followed by early extubation less detrimental than lower levels of PEEP for extended periods of mechanical ventilation («low stretch strategy») [7] ?
How should PEEP be set up?
1) end-inspiratory pressure to the limit?
Can strategy [47] 2) end-expiratory pressure to the limit?
End-expiratory transpulmonary pressure is set slightly positive (0−10 cm H 2 O: Fig. 2E in [48] ) to avoid cyclical alveolar end-expiratory collapse (endinspiratory limit: 25 cm H 2 O). The use of a high end-expiratory transpulmonary pressure = 10 cm H 2 O is restricted to FIO 2 = 1.0 according to the NIH Table [48]: Table 4A , part I. Could a higher end-expiratory transpulmonary pressure be used? Presumably this pertains to the use of SV: PS, APRV, etc. as opposed to CMV?
3) end-inspiratory pressure to the limit combined to end-expiratory pressure to the limit? How may the esophageal catheter be used in the setting of high PEEP-low PS?
As long as the end-inspiratory transpulmonary pressure does not exceed 27−44 cm H 2 O for a very limited period of time to be defined, could a high end-inspiratory pressure be used combined to a high transpulmonary end-expiratory pressure (e.g., 10 cm H 2 O [48] or more?) be used until the FIO 2 is ≤ 0.4, then PEEP lowered? 4) is the PEEP necessary to maintain acceptable oxygenation (SaO 2 = 88−92% under CMV [42] identical or different from the PEEP necessary to avoid cyclical end-expiratory alveolar collapse (see [48] )?
II. Maintaining PEEP:
How long should an adequately high level of PEEP be maintained to counteract atelectasis (strictly speaking: the loss of aeration/collapse) or inflammation or increased lung water? accordingly how long should the intervals between PEEP lowering be: 6 h? 12 h? more? Some indications may be found in the ART trial [151] . Improvement of oxygenation presents 2 different time courses (minutes/hours vs. 12 to 72 h): 1) Kirby [90] , Borges [91] , and Grasso [47] showed an improvement over a few hours, as they use high PEEP [90] vs. recruitment maneuvers [91] vs. PEEP tailored to end-inspiratory transpulmonary pressure [47] .
2) other studies show an improvement over a few days (3−5 d) as they use either spontaneous ventilation-assisted breathing [20, 21] vs. a low stretch strategy [64] vs. medium-high PEEP [92] (Table 7 , part I) vs. end-expiratory transpulmonary pressure [48] . Accordingly, an increase in PEEP from 5 to 15 cm H 2 0 does not lead to an equilibrium in oxygenation even after 60 min in the setting of ARDS (P/F = 177 ± 71) and may "reflect a progressive modification of the underlying pulmonary pathology, rather than the achievement of a new steady state" [152] : the unfolding of collapsed alveoli? decreased lung water? decreased inflammation?
The NIH table (Table 4A , part I [42] ) implies that the FiO 2 and PEEP should be lowered simultaneously. Our observations [28, 30, 71] do not fit with this proposition [42] . Our observations fit with the second group: P/F increased from ≈50 to ≥ 150−200 over 12−72 h. This implies that PEEP is not to be lowered simultaneously with FiO 2 , contrary to the suggestion of the NIH table (Tables 4A, part I and 1, part II).
Decreased muscle tone of inspiratory muscles affects FRC unfavourably [95] . Accordingly, does a preserved muscle tone (i.e., no anaesthetics/opioid analgesics/conventional sedatives but "cooperative" sedation with alpha-2 agonists [13] ) affect FRC favourably, once an acceptable P/F is observed?
III. Extubation:
When should extubation be considered? Presumably, this is a function primarily of the overall status of the patient him/herself (i.e. circulation, kidney injury, infection, inflammation, tissue edema/weight), secondly of the ventilatory status and lastly, of the follow-up: intensive physiotherapy/ /rehabilitation and non-invasive ventilation, up to discharge from the CCU? a) P/F > 150 with PEEP ≤ 10 cm H 2 O: the criteria to switch from non-invasive ventilation to tracheal intubation-invasive ventilation uses a P/F < 150 as a cut-off point. Does reverse thinking apply? Although this has been accepted throughout this article, this requires evidence-based demonstration, irrespective of the use of CMV vs. SV. (50) is set (Vt ≤ 5 mL kg −1 [51] ); this implies lowering the VO 2 . Then, the PEEP is increased to Pplat = 30 cm H 2 0. Next, the "trial" PEEP is set to SaO 2 = 88−92% under CMV [41, 52, 53] using the high PEEP-low FiO 2 table [42] (Table 4 , part I). The next morning, sophisticated investigations (e.g., CT scan, electrical impedance tomography, balloon, or trial-PEEP [54] ) will allow the titration of an individualized PEEP. b) SV is considered as soon as the acute cardio-ventilatory distress improves [7] . Because the Vt cannot be fixed under PS, the rationale for setting the PEEP before the Vt holds in reverse. First, the PEEP is set to avoid endexpiratory collapse above the critical closing pressure and to target the end-expiratory transpulmonary pressure, the decremental limb of the P−V curve or a higher pre-defined SaO 2 (trial PEEP; SaO 2 ≥ 98−100%; Table 4 , part I). [Then, a minimized VO 2 ( Table 2 , part II), an acceptable hypercapnia [55] , a relatively high PO 2 evoking a low RR [40] , and a PS set to the minimum [30] will generate the lowest Vt (≤ 5− -6 mL kg −1 ) and minimize firstly: i) the use of respiratory muscles (palpation of SCM; Fig. 3 in [18] ) with a low inspiratory trigger, automatic tube compensation [56] , rapid pressure rise time [57, 58] ; and ii) the inspiratory transpulmonary pressure (low expiratory trigger [59] ; Figs 1 and 2 in [33] ; Fig. 1 in [37] )].
ii. PERSPECTiVES a. strategies to handle early severe ards:
requirements
Irrespective of any preference for controlled vs. spontaneous ventilation, the oxygenation defect should be analytically corrected ( §I) (i.e., up-front circulatory optimization, position, normothermia in order to minimize VO 2 , CT scan, fiberoptic aspiration, anti-infectious strategy, ERR, itemized assessment of CO 2 vs. H + drive, and sympathetic de-activation). To ascertain ARDS, the P/F should be re-assessed after 30 min of standardized ventilation [60] (Vt≈7 mL kg −1 , PEEP = 10 cm H 2 O, and FiO 2 = 1.0). The reader should be aware that the PEEP = 10 cm H 2 O suggested by Ferguson (60) is higher than the PEEP = 5 cm H 2 O required by the Berlin definition [61] , biasing the selection towards more severe ARDS. Both a low driving pressure [50] and a high PEEP [62] appear to be mandatory in early diffuse ARDS. The Pplat should be based on the end-inspiratory PL (up to 25 cm H 2 O) [47] while the PEEP should be based on the end-expiratory PL (0−10 cm H 2 O) [48] . Swiftness is mandatory due to comorbidities and CCU-acquired diseases; minimizing muscle relaxation (≈5 d) and sedation (≈10 d) is key, irrespective of the assignment in the prone vs. supine position [63] , in order to improve the outcome. This swiftness is at odd with a "low stretch" strategy that relies on prolonged intubation [7] (CMV up to improvement followed by PS as quickly as possible; low PEEP < 10 cm H 2 O with a Pplat < 29 cm H 2 O combined with inotropic/vasopressor support if necessary; historic group ~14 d of CMV; recent group ~17 d) [64] .
Controlled meChaniCal ventilation: "ProteCtive" ventilation
"Protective" ventilation ( Fig. 1 in [65] ) is now optimized and includes a high PEEP [62, 66] , a Pplat that is as low as possible [51, 67] (Fig. 2 in [51 O or Vt ≈ 6 mL kg −1 ) lead to a high PEEP and low driving pressure only for the time necessary to stabilize a sick patient ("Friday night ventilation" [11] ) and to differentiate focal vs. diffuse ARDS [75, 76] . However, these "magic" numbers expose ~30% of patients to hyperinflation [68] . Therefore, an individualized approach to optimize the end-inspiratory [47] vs. end-expiratory transpulmonary pressure [48] should be adopted as early as possible; this end-expiratory approach will improve oxygenation in severe ARDS [47, 48] and reduce mortality (P = 0.049 on 28 d mortality, n = 30 vs. 31 [48] ). [2, 63] . Indeed, the only interventions to withstand the test of outcome [77] are, so far, low Vt/driving pressure [50] , muscle relaxants, and the prone position [2, 63, 77, 78] .
Individualized Vt and individualized PEEP during muscle relaxation combined with proning remains the accepted practice in 2016
Cmv FolloWed By early transition to sv
[When severe acute hypoxemic respiratory failure is observed alone i.e. within the setting of single organ failure [27, 28, 30, 71] , SV with high PEEP appears to be suitable within 3−12 h following normothermia, controlled H + status, intubation, the insertion of lines, imaging, fibre optic bronchoscopy, and a CT scan. In contrast, when uncontrolled infection and severe metabolic acidosis evoke early MOF, an anti-infectious strategy, extrarenal replacement and normothermia should aggressively control the VO 2 and H + prior to the initiation of SV [28] . Given these caveats (II A 1), in the setting of single-organ failure, a high PEEP (typically ≥ 15−20 cm H 2 O) combined with prone positioning early in severe ARDS dramatically improves the P/F over ~24 h with only one session of prone positioning (Quintin, unpublished data) . Thus, the CMV may be switched to PS as soon as the SV has recovered after the interruption of muscle relaxants. This schema (III-A 3) is halfway between the schema § II A 2 (muscle relaxant for 24 [5] or 48 h followed by SV [2, 6] ) and the schema § II B (early high PEEP-low PS under alpha-2 agonists [27, 28, 30, 71] [7] . Thus, a "one-size-fits-all" strategy gives way to a patient-by-patient approach].
b. anything new under the sun? yes: analytical ManageMent!
[So, what is new in early severe ARDS? The understanding that has emerged from the ARDS conundrum over the last 50 years currently allows, at this moment, ARDS to be analytically addressed. Thus, circulation (venous return, RV afterload, and LV preload [7] ), ventilation (H + , CO 2 , O 2 , RR, and Vt), position ("upright" position [79−81] ), VO 2 [45, 70, 82] , temperature [45] , intact respiratory neurogenesis, sympathetic de-activation, inflammation, and reduced lung water should be disentangled, one after the other, analyzed and normalized as early as possible to allow for early spontaneous ventilation.
Two different time intervals should be separated: 1) Acute cardio-ventilatory distress ("shock" state): what should be done immediately when a severe ARDS patient arrives at 10 pm in the CCU? Reference [11] delineates a neat step-by-step approach for the management of acute cardio-ventilatory distress. The consensus [2, 11, 63] works nicely as long as the acute cardio-ventilatory distress is considered [11] . Given the remarkable achievements of CMV + muscle relaxation + proning [63] , campaigning for SV ( [27, 30, 71] when all investigations (i.e., CT scan and bronchoscopy), physiological measurements (i.e., pressure-volume curve: P-V curve, esophageal catheter: "balloon", and trial-PEEP), and expertise are available. Indeed, a) the use of synchronized IMV in an early trial led to a mortality rate of 16% [83] using synchronized IMV; b) a total of 79% of the patients using synchronized IMV; a total of 79% of the patients (P/F < 300) were managed with PS as long as the RR did not increase disproportionately [39] . These results favour SV [5, 12, 20, 26, 38, 84−89] or APRV+SV [21, 24] .
All groups [5] [6] [7] 12] emphasize the necessity to switch to SV as early as possible. Irrespective of the CMV vs. SV strategy, achieving a P/F ≥ 150−200 swiftly should be the concern (~30 min [47] vs. a few hours [90, 91] vs. a few days [28, 30, 48, 71, 92] ). The take-home message remains: "avoid tracheal tubes, minimize sedation, prevent ventilator-induced lung injury and nosocomial infections" [69] . Thus, we [27, 28, 30, 71, 93] capitalize on previous approaches to move faster in the same direction. Stringent physiological principles are to be met analytically, irrespective of an emphasis on early SV [27, 28, 30, 71, 93] as opposed to CMV ± proning [2, 63] . Preserved respiratory neurogenesis [94] , preserved respiratory muscle power and tone [95] , the West schema drawn in an upright position (Fig. 11 in [96] ) and adequate diaphragmatic mechanics ( Fig. 1 in [97] ) are to be kept in mind: therefore, general anaesthesia (hypnotics, opioid analgesics, muscle relaxant i.e., "analgo-sedation") combined with CMV and/ /or proning makes little sense [95] in a patient with early severe stabilized ARDS. Some argue that "the evidence for beneficial effects of spontaneous breathing has been gathered in less severe… ARDS with modest ventilatory demands" [98] . Thus, as argued iteratively throughout the present review, analysis is key: in early severe ARDS, the temperature, Vt, RR, CO 2 and H + drives should be fully normalized to lower ventilatory and metabolic demands [45] before heading to spontaneous ventilation. SV and CMV are in a continuum rather as opposed to the two sides of the Great Wall of China. Furthermore, is there any reason [98] to separate moderate and severe ARDS? This distinction [98] does not hold (Fig. 1 in [29] ) as the same overall principles apply irrespective of mild vs. moderate vs. severe ARDS [29] . Accordingly, a trial is presently underway using APRV + SV in early ARDS (BIRDS trial: clinicaltrials.gov/ct2/show/ NCT01862016).
Lowering the mortality in severe ARDS (~16% in the best series) [63, 83] 
iii. CONCLUSiON
Early severe ARDS is neither a failure of the ventilatory pump nor of respiratory neurogenesis. Instead, ARDS is caused by a reduction in the surface for O 2 diffusion in the early stage (restrictive disease) and an iatrogenic disease in the later stages [75, 95, 99, 100] . The early management of severe ARDS should be thoroughly analytical. Early recruitment [62] without overdistension [68] aims toward swift extubation in order to avoid CCU-acquired diseases. Under stringent conditions (circulation, upright position, VO 2 /temperature, acidosis, PaCO 2 , work of breathing, tidal volume, respiratory rate, absence of respiratory depression, sympathetic de-activation, suppressed agitation: Table 1 , part II), spontaneous ventilation [5, 12, 20, 21, 26−28, 30, 38, 71, 84−89] requires an evidence-based demonstration. Controlled mechanical ventilation with muscle relaxants [2] and proning [63] remain, in 2016, the accepted practice [11] . Ongoing research ([101] and Table 2 , part II) on the pathophysiology of ARDS will simplify its management and reduce mortality. 
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